Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	FP-1201-lyo 10 μg	144
Overall Study	STARTED	Placebo	152
Overall Study	Subjects Randomised	FP-1201-lyo 10 μg	146
Overall Study	Subjects Randomised	Placebo	155
Overall Study	Short-Term Follow-Up (Day 28)	FP-1201-lyo 10 μg	105
Overall Study	Short-Term Follow-Up (Day 28)	Placebo	115
Overall Study	Long-Term Follow-Up (Day 90)	FP-1201-lyo 10 μg	96
Overall Study	Long-Term Follow-Up (Day 90)	Placebo	101
Overall Study	Long-Term Follow-Up (Day 180)	FP-1201-lyo 10 μg	73
Overall Study	Long-Term Follow-Up (Day 180)	Placebo	74
Overall Study	COMPLETED	FP-1201-lyo 10 μg	51
Overall Study	COMPLETED	Placebo	49
Overall Study	NOT COMPLETED	FP-1201-lyo 10 μg	93
Overall Study	NOT COMPLETED	Placebo	103

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02622724/flow